Sofinnova Investments, Inc. - CYTOKINETICS INC ownership

CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 256 filers reported holding CYTOKINETICS INC in Q3 2023. The put-call ratio across all filers is 2.72 and the average weighting 0.2%.

Quarter-by-quarter ownership
Sofinnova Investments, Inc. ownership history of CYTOKINETICS INC
ValueSharesWeighting
Q3 2023$45,962,431
+67.1%
1,560,164
+85.0%
2.90%
+60.9%
Q2 2023$27,506,097
+120.9%
843,228
+138.3%
1.80%
+126.4%
Q1 2023$12,450,081
-55.4%
353,796
-41.9%
0.80%
-51.9%
Q4 2022$27,901,173
+79.6%
608,930
+89.9%
1.66%
+83.2%
Q3 2022$15,539,000
+23.3%
320,722
-0.0%
0.90%
-13.9%
Q2 2022$12,603,000
+443.9%
320,780
+409.6%
1.05%
+496.6%
Q1 2022$2,317,000
-89.1%
62,944
-86.4%
0.18%
-85.8%
Q4 2021$21,166,000
+38.8%
464,366
+8.8%
1.24%
+36.9%
Q3 2021$15,248,000
+60.1%
426,632
-11.4%
0.90%
+64.5%
Q2 2021$9,525,000
+5.1%
481,323
+23.5%
0.55%
+0.7%
Q1 2021$9,065,000
-14.2%
389,720
-23.3%
0.54%
-13.4%
Q4 2020$10,564,000
+39.7%
508,394
+45.5%
0.63%
+12.1%
Q3 2020$7,562,000
+100.3%
349,296
+118.0%
0.56%
+135.7%
Q2 2020$3,776,000
+57.3%
160,217
-24.1%
0.24%
+9.7%
Q3 2019$2,401,000210,9920.22%
Other shareholders
CYTOKINETICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 223,382$6,580,8347.72%
Finepoint Capital LP 431,693$12,717,6766.33%
Saturn V Capital Management LP 495,168$14,587,6496.11%
Logos Global Management LP 1,250,000$36,825,0004.91%
DAFNA Capital Management LLC 479,538$14,127,1894.39%
PFM Health Sciences, LP 2,399,545$70,690,5963.33%
Boxer Capital, LLC 2,100,000$61,866,0003.29%
Integral Health Asset Management, LLC 800,000$23,568,0003.26%
GREAT POINT PARTNERS LLC 600,000$17,676,0003.22%
Nicholas Investment Partners, LP 942,137$27,755,3562.07%
View complete list of CYTOKINETICS INC shareholders